Product Description
Overall, the global autotransfusion device market was valued at $230 million in 2023. This is expected to increase over the forecast period at a CAGR of 1.3% to reach $250 million.
The full report suite on the global market for autotransfusion device includes autotransfusion disposable kits and autotransfusion machines.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Disease Overviews
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Autotransfusion Market Insights
MARKET SHARE INSIGHTS
In 2023, LivaNova emerged as a dominant force in the global autotransfusion sector. With over three decades in the industry, the company strengthened its position with the launch of its innovative XTRA autotransfusion machine and a steadfast commitment to market expansion.
Haemonetics held the second position, offering advanced solutions like the Cell Saver® Elite® systems in the U.S. market. Despite its strong presence, market dynamics with LivaNova and Medtronic suggest a potential decline in Haemonetics’ market share in the future.
Medtronic secured the third spot, introducing the AutoLog IQ™, priced slightly higher than its predecessor, enhancing its portfolio with essential disposables for autotransfusion procedures. Following its exit from the ventricular assist device market, Medtronic is poised to increase its stake in the autotransfusion market.
MARKET SEGMENTATION SUMMARY\
- Autotransfusion Machines
- Autotransfusion Disposables
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |